Phase I/II study of the oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma (RCC).

医学 队列 肾细胞癌 内科学 肾透明细胞癌 恶心 临床终点 贫血 胃肠病学 不利影响 肿瘤科 临床研究阶段 泌尿科 外科 毒性 临床试验
作者
Toni K. Choueiri,Elizabeth R. Plimack,Todd M. Bauer,Jaime R. Merchan,Kyriakos P. Papadopoulos,David F. McDermott,M. Dror Michaelson,Leonard J. Appleman,Sanjay Thamake,Naseem J. Zojwalla,Eric Jonasch
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:38 (6_suppl): 611-611 被引量:37
标识
DOI:10.1200/jco.2020.38.6_suppl.611
摘要

611 Background: Hypoxia-inducible factor (HIF)-2α is a transcription factor that is a key oncogenic driver in RCC. MK-6482 is a first-in-class small molecule HIF-2α inhibitor that blocks the heterodimerization of HIF-2α with HIF-1β and induces regression in mouse xenograft RCC models. Methods: Pts with advanced ccRCC who had received at least 1 prior therapy were enrolled in an expansion cohort from the first-in-human phase 1/2 study of MK-6482 in advanced solid tumors (NCT02974738). Pts were administered 120 mg of MK-6482 orally once daily. Primary end point: safety. Key secondary end points: ORR, duration of response (DOR), and PFS. Results: Fifty-five pts were enrolled in the dose expansion cohort. Median (range) number of prior therapies was 3 (1-9); 67% received anti–PD-1 and anti-VEGF agents. Five pts (9%) were favorable risk, 40 (73%) were intermediate risk, and 10 (18%) were poor risk by IMDC criteria. With a median follow-up of 13 mo the most common all-grade, all-cause AEs > 30% were anemia (75%), fatigue (67%), dyspnea (47%), nausea (33%), and cough (31%). Anemia (26%) and hypoxia (15%) were the most common grade 3 AEs. No grade 4/5 drug-related AEs were observed. ORR was 24% with 13 confirmed PRs. Thirty-one pts (56%) had SD, with a disease control rate (CR+PR+SD) of 80%. Thirty-five of 52 (67%) pts with baseline and postbaseline assessments had tumor shrinkage. Median DOR was not reached; 81% of pts had response ≥6 mo per Kaplan-Meier estimate. Sixteen pts (29%) continued treatment beyond 12 mo. By IMDC risk, 2/5 pts with favorable risk had PR (ORR = 40%), 10/40 with intermediate risk had PR (ORR = 25%), and 1/10 with poor risk had PR (ORR = 10%); disease control rate was 100%, 80%, and 70%, respectively. Median PFS for the total population was 11.0 mo; the 12 mo PFS rate was 49%. Median PFS for favorable, intermediate, and poor IMDC risk was 16.5, 11.0, and 6.9 mo, respectively. As of May 15, 2019, 30 pts (55%) discontinued due to PD, 2 (4%) due to AEs. Sixteen pts (29%) had treatment ongoing. Conclusions: MK-6482 is well tolerated with a favorable safety profile and demonstrated promising single-agent activity in heavily pretreated pts with ccRCC across IMDC risk groups. A phase 3 trial in a similar population is planned. Clinical trial information: NCT02974738.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今天只做一件事完成签到,获得积分0
刚刚
PSC完成签到,获得积分10
1秒前
eueurhj发布了新的文献求助30
1秒前
小二郎应助迪克牛仔采纳,获得10
2秒前
一直向前发布了新的文献求助10
3秒前
明芬完成签到,获得积分10
6秒前
7秒前
123456完成签到,获得积分10
10秒前
结实的慕凝完成签到,获得积分10
12秒前
苗条小土豆完成签到,获得积分10
12秒前
flance完成签到 ,获得积分10
14秒前
15秒前
fanfan完成签到 ,获得积分10
17秒前
SkyTsai完成签到,获得积分10
17秒前
20秒前
21秒前
轻松的惜芹应助诚心谷南采纳,获得10
21秒前
天天快乐应助sml采纳,获得10
22秒前
24秒前
25秒前
25秒前
华仔应助sxx采纳,获得10
28秒前
YJ888发布了新的文献求助10
29秒前
30秒前
哼哼唧唧发布了新的文献求助10
30秒前
石大大发布了新的文献求助10
32秒前
huoguo完成签到,获得积分10
33秒前
小二郎应助完美芒果采纳,获得10
33秒前
Liufgui应助紫竹魔笛采纳,获得10
35秒前
36秒前
38秒前
Liufgui应助YJ888采纳,获得10
39秒前
赘婿应助麦子采纳,获得10
39秒前
40秒前
KK发布了新的文献求助10
40秒前
娟姐完成签到,获得积分10
41秒前
ding应助李朝富采纳,获得10
42秒前
桐桐应助学术蝗虫采纳,获得10
43秒前
杨桃发布了新的文献求助10
43秒前
44秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989550
求助须知:如何正确求助?哪些是违规求助? 3531774
关于积分的说明 11254747
捐赠科研通 3270278
什么是DOI,文献DOI怎么找? 1804966
邀请新用户注册赠送积分活动 882125
科研通“疑难数据库(出版商)”最低求助积分说明 809176